Capricor Therapeutics | ARS: Annual Report to Security Holders
Capricor Therapeutics | DEF 14A: Definitive information statements
Capricor Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Capricor Therapeutics | 10-K: Annual report
Capricor Therapeutics | 8-K: Capricor Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Capricor Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Capricor Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Highbridge Capital Management, LLC(9.1%)
Capricor Therapeutics | 8-K: Current report
Capricor Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Krasney Karen
Capricor Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Marban Linda
Capricor Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Litvack Frank
Capricor Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director COLLIER EARL M JR
Capricor Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Sabar Karimah Es
Capricor Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director DUNBAR GEORGE W JR
Capricor Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Musket David B
Capricor Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Auwaerter Paul Gisbert
Capricor Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Gotwals Philip J
Capricor Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Kelliher Mike
Capricor Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bergmann Anthony
Capricor Therapeutics | 8-K: Current report
No Data